August 11, 2025 7:42am

After 1 positive of 10 negative closes <since 7/28> and 6 negative closes <since 8/1>

Today’s main takeaway … traversing the volatility tripwire! While, inflation readings this week will prove a key hurdle for a broad market index near record highs. The consumer price index, which is set to be released Tuesday, and the producer price index, due out Thursday, will be critical in shaping the outlook for the direction of interest rates, especially for the Fed’s September meeting. Hotter inflation could hinder the market’s advance. Inflation data comes ahead of the Fed’s Jackson Hole meeting in Wyoming on Aug. 21-23, which will likely set the tone for the September meeting.

Earnings: 8/11, Monday = Agenus (AGEN) and Compass Therapeutics (CMPX)

My interpretation of the morning’s numbers is written to be informative; it’s built on what happened to make “it” happen today!

Never leave an investor uninformed … I say what others won’t, so you can do what others can’t!

Remember that overnight and pre-open actions’ futures and markets doesn’t necessarily translate into actual trading in today’s market session.

There are buying opportunities and sell signals, but many names are likely to reverse direction after the open, especially following earnings.

My “posts” are conveyed with a simplicity of language to highlight what is informative.

 

Friday’s night’s … RegMed Investors (RMi) Closing Bell: Indexes climb as cell and gene therapy continues stumbling … https://www.regmedinvestors.com/articles/14055

RegMed Investors (RMi) Research Note: Harvard Apparatus GT (OTCQB): Navigating the next re-calibration, yet another "Exempt Offering of Securities" … https://www.regmedinvestors.com/articles/13812

 

Monday: The pre-open Dow futures are UP +0.28% or (+125 points), the S&P futures are UP +0.14% or (+9 points) and the Nasdaq futures are UP +0.06% or (+15 point)

  • U.S. stock futures are flitting higher, Monday 8/11,
  • European indexes/bourse opened higher and falling
  • Asia-Pacific markets were trading subdued Monday as investors awaited official announcement on whether the Aug. 12 deadline for U.S.–China tariff truce would be extended.

 

Henry’omics: We need to more than consider the economic environment to comprehend the micro re “our” universe of cell and gene therapy companies

  • Friday: The Dow closed UP +206.97 points or +0.47%, the S&P closed UP +49.45 points or +0.78% while the Nasdaq closed UP +207.32 points or +0.98%
  • Thursday: The Dow closed DOWN -224.48 points or -0.51%, the S&P closed DOWN -5.06 points or -0.08% while the Nasdaq closed UP +73.27 points or +0.35%
  • Wednesday: The Dow closed UP +81.38 points or +0.18%, the S&P closed UP +45.87 points or +0.73% while the Nasdaq closed UP +252.87 points or +1.21%
  • Tuesday: The Dow closed DOWN -61.90 points or -0.14%, the S&P closed DOWN -30.77 points or -0.49% while the Nasdaq closed DOWN -137.03 points or -0.65%
  • Monday: The Dow closed UP +585.06 points or +1.34%, the S&P closed UP +91.93 points or +1.47% while the Nasdaq closed UP +403.45 points or +1.95%
  • Last week, the S&P 500 has gained 2.5%, the Nasdaq has added +3.9% and the Dow has advanced 1.4%.
  • The previous week, the Dow tumbled -2.9%, the S&P 500 dropped -2.4% and the Nasdaq lost -2.2%

Economic Data Docket: None

 

Q3 – August - 5 negative and 1 positive closes

•             July – 1 market holiday, 13 positive and 9 negative closes

 

Companies in my headlights – It’s your decision; I provide ideas and context

I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths.  A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.

  • I’ll pass; …. an escape of more earnings releases, this week’s econs and the usual ups, downs and just plain uncertainty
  • Although: After too many downs, there is soon to be an ascension

 

The BOTTOM LINE: U.S. stock index futures were “barely” <little changing> on Monday, 8/11 as investors geared up for a busy week, waiting for the next turn in trade policy ahead of a key tariff deadline with China.

  • Traders seem to be taking a breather, last week's mixed closes so called, rally helped the S&P 500 and the Nasdaq log their strongest weekly performance in more than a month.
  • Amid earning’s declines, we are have seen “too much red” on the screen …
  • Markets also await clarity on the sector tariffs.

Tuesday's consumer inflation report will either cast more doubt or offer clarity for investors, who are currently anticipating the Fed will lower borrowing costs by about 60 basis points by December, according to data compiled by LSEG.

Gene therapy developers fell, with Sarepta Therapeutics (SRPT) dropping 7.6% and Capricor Therapeutics (CAPR) declined 9% as Vinay Prasad, a fierce critic of U.S. COVID-19 vaccine and mask mandates, was expected to return to the FDA. <Reuters>

August: understand the “flow” …

  • 8/8 – Friday closed negative with 11 positive, 23 negative and 1 flat
  • 8/7 – Thursday closed negative with 9 positive, 24 negative and 2 flats
  • 8/6 – Wednesday closed negative with 11 positive, 22 negative and 2 flats
  • 8/5 – Tuesday closed negative with 15 positive, 19 negative and 1 flat
  • 8/4 – Monday closed positive with 27 positive, 8 negative and 0 flats
  • 8/1 – Friday closed negative with 9 positive, 20 negative and 6 flats

Last Week:

  • 7/31 - Thursday closed negative with 3 positive, 25 negative and 7 flats
  • 7/30 - Wednesday closed negative with 12 positive, 18 negative and 5 flats
  • 7/29 – Tuesday closed negative with 8 positive, 22 negative and 5 flats
  • 7/28 – Monday closed negative with 14 positive, 16 negative and 5 flats

 

Earnings are still the highlight of the week: Meeting earnings expectation and/or missing consensus will deem share pricing outcomes.

  • Earnings:  4 net incomes and 17 net losses of 21 releases to date
  • Upcoming: 8/14, Thursday = Brainstorm Cell Therapeutics (BCLI)

 

“I also hate to be so negative or contrarian but, this is a NO spin zone and truth is its product; I can always be WRONG but, I am mostly EARLY!”

 

Reiterating, “There are always some big ifs, especially given some of the headlines that could emanate after a past few months of news flatulence.

  • As always, I brace myself for earnings associated with share pricing volatility, some economics and tariff developments and their effects?

Welcome to my world of defining the “grey’ in our universe!

  • I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.  Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities.

 I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed.